ABION is a global precision oncology biotech company with a mission to address the critical issue of cancer and contribute to the well-being of humanity. Through relentless and innovative research and development of cutting-edge anti-cancer therapies, ABION aims to improve the lives of patients suffering from rare diseases and intractable illnesses. The company strives to discover and commercialize key new drug candidates through continuous research and development, collaborating with prominent domestic and international biopharmaceutical companies.

With a focus on global innovation and possessing integrity, ABION pursues drug development based on the highest standards of data integrity. The company provides opportunities for its team of experts to shine, fostering professionalism in various fields. ABION is committed to sustainability, aiming for continuous research and development and fulfilling its social responsibilities.

With a well-defined R&D strategy, ABION leverages its specialized research workforce and technology exports to generate revenue and accelerate the pace of development. Trust ABION as it becomes a leading global biotech company